Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds

Anna Lichota1, Eligia M Szewczyk1, Krzysztof Gwozdzinski2

  • 1Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Faculty of Pharmacy, Medical University of Lodz, 90-235 Lodz, Poland.

Insights

Venous thromboembolism (VTE), including deep vein thrombosis (DVT), is a major cardiovascular disease. This review explores factors influencing blood clot formation and discusses current and traditional treatments.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pathophysiology

Background:

  • Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of morbidity and mortality.
  • DVT involves blood clot formation in deep veins, leading to altered blood flow and cellular responses.
  • Thrombosis is the third leading cardiovascular disease globally.

Purpose of the Study:

  • To review the factors influencing hemostatic disorders and blood clot formation.
  • To discuss the mechanisms of thrombosis, including cellular and molecular players.
  • To examine current and traditional therapeutic strategies for VTE.

Main Methods:

  • Literature review of factors affecting hemostasis and thrombosis.
  • Analysis of mechanisms involving hypoxia, endothelial cells, platelets, and neutrophils.
  • Review of anticoagulant and antiplatelet drug actions.
  • Exploration of natural anticoagulants from plant sources.

Main Results:

  • Blood clot formation involves fibrin, platelets, and blood cells, influenced by factors like hypoxia and reactive oxygen species (ROS).
  • Endothelial cells, platelets, and neutrophils play critical roles in thrombosis pathogenesis.
  • Anticoagulants and antiplatelet drugs target coagulation factors and platelet activation.
  • Natural anticoagulants from traditional Eastern medicine offer potential therapeutic avenues.

Conclusions:

  • While significant progress has been made, the pathogenesis of thrombosis requires further clarification.
  • A comprehensive understanding of thrombosis mechanisms is crucial for developing effective treatments.
  • Investigating natural anticoagulants may reveal novel therapeutic targets for VTE prevention and management.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.9K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
158
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.7K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
146
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K